다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GTBP

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/08	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2024/05/24	09:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
2024/05/23	19:04	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GTBP	GT Biopharma Inc
2024/05/23	19:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2024/05/16	06:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
2024/02/15	04:46	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
2024/02/02	02:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/12/22	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/12/05	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/11/07	07:25	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
2023/11/07	07:23	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
2023/11/07	07:21	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:GTBP	GT Biopharma Inc
2023/11/01	22:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
2023/10/28	06:23	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:GTBP	GT Biopharma Inc
2023/09/20	00:56	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:GTBP	GT Biopharma Inc
2023/08/23	05:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/08/16	08:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
2023/08/16	08:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
2023/08/07	22:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
2023/07/05	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/05/06	06:30	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:GTBP	GT Biopharma Inc
2023/05/06	06:29	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	NASDAQ:GTBP	GT Biopharma Inc
2023/05/05	08:15	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:GTBP	GT Biopharma Inc
2023/05/04	22:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc
2023/04/12	08:00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GTBP	GT Biopharma Inc
2023/03/31	06:02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:GTBP	GT Biopharma Inc
2023/02/15	02:55	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GTBP	GT Biopharma Inc
2023/01/04	20:23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc
2023/01/04	20:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:GTBP	GT Biopharma Inc
2022/12/14	06:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc

검색 관련기사 보기:NASDAQ:GTBP

1 2 3 4 다음 >>

Gold vs US Dollar

Verizon Communications

Bank of America

JP Morgan Chase

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관